OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells
Koichi Ohno, Tomohiro Shibata, Ken‐ichi Ito
Cancer Science (2022) Vol. 113, Iss. 9, pp. 3193-3210
Open Access | Times Cited: 8
Koichi Ohno, Tomohiro Shibata, Ken‐ichi Ito
Cancer Science (2022) Vol. 113, Iss. 9, pp. 3193-3210
Open Access | Times Cited: 8
Showing 8 citing articles:
Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning
Yanyan Liu, Zhenglang Yin, Yao Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
Yanyan Liu, Zhenglang Yin, Yao Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer
Valentina Cirello, Carla Colombo, Delfina Tosi, et al.
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access
Valentina Cirello, Carla Colombo, Delfina Tosi, et al.
The Journal of Clinical Endocrinology & Metabolism (2025)
Open Access
Challenges and Strategies to Combat Resistance Mechanisms in Thyroid Cancer Therapeutics
Matti L. Gild, Martyn Bullock, Venessa Tsang, et al.
Thyroid (2023) Vol. 33, Iss. 6, pp. 682-690
Closed Access | Times Cited: 12
Matti L. Gild, Martyn Bullock, Venessa Tsang, et al.
Thyroid (2023) Vol. 33, Iss. 6, pp. 682-690
Closed Access | Times Cited: 12
FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis
Huili Pan, Zhiyan Luo, Lin Feng, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access | Times Cited: 2
Huili Pan, Zhiyan Luo, Lin Feng, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access | Times Cited: 2
Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma
Vasileios Papanikolaou, Efthymios Kyrodimos, Nicholas Mastronikolis, et al.
Cancer Diagnosis & Prognosis (2023) Vol. 3, Iss. 2, pp. 151-156
Open Access | Times Cited: 5
Vasileios Papanikolaou, Efthymios Kyrodimos, Nicholas Mastronikolis, et al.
Cancer Diagnosis & Prognosis (2023) Vol. 3, Iss. 2, pp. 151-156
Open Access | Times Cited: 5
Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma
Yinli Shi, Pei Sheng, Ming Guo, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
Yinli Shi, Pei Sheng, Ming Guo, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer
Ryutaro Onaga, Tomohiro Enokida, Susumu Okano, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 10, pp. 1435-1443
Closed Access
Ryutaro Onaga, Tomohiro Enokida, Susumu Okano, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 10, pp. 1435-1443
Closed Access
